
75. What does a mainstream cardiologist think of my cholesterol? With Nadir Ali, MD
Paul Saladino MD podcast
00:00
Concerns about PCSK9 inhibitor outcomes
They critique PCSK9 inhibitor trials, discussing Fourier results and possible increased all-cause mortality.
Play episode from 57:26
Transcript


